Louis Chênevert on How to be an Effective CEO

Building a successful empire is no child’s play. A leading force in the business and technology industries, Louis Chênevert, gives key insight on how to lead a business the right way.

1. The Right Mentality:
What do eagles and great CEOs have in common? They are both sharp-sighted. A proper leader always has a glorious vision for the future. The ticking clock serves as a motivation to achieve and do more at a faster pace. An awe-inspiring leader understands that his duty is to get the engine started and to add to the firepower of the company, leaving a trail for his fellow successors.

2. Providing Opportunity for Growth:
Celebrating its 20th anniversary, UTC has invested more than $1.2 billion in its Employee Scholar Program, facilitating workers by bringing education programs at their very locations. UTC is dedicated to ensuring that their employees are equipped with the necessary skills and knowledge to flourish not only in the industry but in any part of the world. ESP has encouraged more than 45,000 employees to pursue a degree in a field of their choice!

3. Competition is Your Ally:
Competition polishes and hones the skills of its participants, turning them into precious diamonds. In the business world, competitiveness leads to team-unity, efficiency, and some dazzling inventions. UTC believes in embracing competitiveness.

Otis has provided its services to Burj Khalifa, Eiffel Tower, CN Tower and others.

The honor reward recipient, Canadian-born Louis Chênevert, accomplished impressive feats in the business world. After receiving a bachelor of commerce degree in production management from HEC Montréal, he began his career with General Motors where he served as Production General Manager for 14 years.

During his 4 years as CEO, Chenêvert was able to increase UTC’s share-price from $37 to a whopping $117. His foresightedness prevented the layoff of engineers something that was trending everywhere at that time. Pratt & Whitney made headlines with its 50% emissions reduction, and 16% fuel reduction GTF engines.

Chenêvert worked with UTC for 19 years. In 2011, he was appointed the chairman of Yale Cancer Center’s Advisory Board and was also listed in U.S. aviation trade magazine.

5AM’s Managerial Partner, Scott Rocklage

Scott Rocklage is often referred to as an example of the ambitious people. It was in the year 2003 that he made a significant step by considering it wise to join the 5AM Ventures. Despite having joined as a mere partner, he was promoted in one year. The elevation took place in the year 2004, and he turned out to be the managing director. Learn more about Scott Rocklage:  http://5amventures.com/team/scott-m-rocklage-phd/

As at now, he is a very experienced doctor alongside healthcare management. He has been giving service in the field for a lengthy period exceeding thirty years. With time, he has acquired himself a lot of leadership qualities and has tactical planning skills which that enhanced the approval of the US New Drug by FDA.

Scott Rocklage has also served as an outstanding leader in the position of the Chairman as well as that of the CEO at Cubist Pharmaceuticals. He also served in the same capacities at Nycomed Salutar. Before this, he occupied the position the Executive Chairperson at Ilypsa and gave support regarding the triumph of Semprus, and Miikana.

He attended the University of California, Berkeley where he attained his Bachelor of Science Degree in Chemistry. This achievement happened before his attainment of Ph.D. from the MIT where he pursued Chemistry as well. Scott Rocklage has carried out research in a research laboratory under the ownership of Richard R Schrock.

The latter is won the Nobel Prize in Chemistry in the year 2005. He is prominence is behind his innovation as the co-invention for more than thirty patents of the United States. He has also done reviews of publications exceeding a hundred. Boston is the base of his offices.

Anytime he attends interviews, he is frank and confidently talks about his life as well as the way he operates to ensure that he gains success in his endeavors from time to time. According to him, it is his routine to spend a day in search of new scientific ideas and in some occasions work with the portfolio while managing the firm. Read more: Scott Racklage | Bloomberg

Additionally, enjoys dealing with medical research that has the potential of serving the problems related to cancer. He intends to save lives and give a long lasting solution to the existing medical conditions.